| O9J | Name: | 2-fluoro-3-methyl-N'-(phenylsulfonyl)-5-(pyridin-2-yl)benzohydrazide | Formula: | C19 H16 F N3 O3 S | SMILES: | c3ccnc(c2cc(C(=O)NNS(c1ccccc1)(=O)=O)c(c(C)c2)F)c3 | InChi: | InChI=1S/C19H16FN3O3S/c1-13-11-14(17-9-5-6-10-21-17)12-16(18(13)20)19(24)22-23-27(25,26)15-7-3-2-4-8-15/h2-12,23H,1H3,(H,22,24) | Definition date: | 2019-06-19 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 2-fluoro-3-methyl-N'-(phenylsulfonyl)-5-(pyridin-2-yl)benzohydrazide |
|
| O9M | Name: | 2-fluoro-3-methyl-N'-(phenylsulfonyl)-5-(pyrimidin-2-yl)benzohydrazide | Formula: | C18 H15 F N4 O3 S | SMILES: | c3ccnc(c2cc(C(=O)NNS(c1ccccc1)(=O)=O)c(c(C)c2)F)n3 | InChi: | InChI=1S/C18H15FN4O3S/c1-12-10-13(17-20-8-5-9-21-17)11-15(16(12)19)18(24)22-23-27(25,26)14-6-3-2-4-7-14/h2-11,23H,1H3,(H,22,24) | Definition date: | 2019-06-19 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 2-fluoro-3-methyl-N'-(phenylsulfonyl)-5-(pyrimidin-2-yl)benzohydrazide |
|
| O9P | Name: | 2-fluoro-3-methyl-N'-(phenylsulfonyl)-5-[(prop-2-en-1-yl)oxy]benzohydrazide | Formula: | C17 H17 F N2 O4 S | SMILES: | [C@H](=C)COc2cc(C(=O)NNS(c1ccccc1)(=O)=O)c(c(C)c2)F | InChi: | InChI=1S/C17H17FN2O4S/c1-3-9-24-13-10-12(2)16(18)15(11-13)17(21)19-20-25(22,23)14-7-5-4-6-8-14/h3-8,10-11,20H,1,9H2,2H3,(H,19,21) | Definition date: | 2019-06-19 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 2-fluoro-3-methyl-N'-(phenylsulfonyl)-5-[(prop-2-en-1-yl)oxy]benzohydrazide |
|
| O9S | Name: | 2-fluoro-3-methyl-N'-(phenylsulfonyl)-5-[(propan-2-yl)oxy]benzohydrazide | Formula: | C17 H19 F N2 O4 S | SMILES: | C(=O)(c1c(c(cc(c1)OC(C)C)C)F)NNS(c2ccccc2)(=O)=O | InChi: | InChI=1S/C17H19FN2O4S/c1-11(2)24-13-9-12(3)16(18)15(10-13)17(21)19-20-25(22,23)14-7-5-4-6-8-14/h4-11,20H,1-3H3,(H,19,21) | Definition date: | 2019-06-19 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 2-fluoro-3-methyl-N'-(phenylsulfonyl)-5-[(propan-2-yl)oxy]benzohydrazide |
|
| O9V | Name: | 2-fluoro-3-methyl-N'-(phenylsulfonyl)-5-propoxybenzohydrazide | Formula: | C17 H19 F N2 O4 S | SMILES: | C(=O)(c1c(c(cc(c1)OCCC)C)F)NNS(c2ccccc2)(=O)=O | InChi: | InChI=1S/C17H19FN2O4S/c1-3-9-24-13-10-12(2)16(18)15(11-13)17(21)19-20-25(22,23)14-7-5-4-6-8-14/h4-8,10-11,20H,3,9H2,1-2H3,(H,19,21) | Definition date: | 2019-06-19 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 2-fluoro-3-methyl-N'-(phenylsulfonyl)-5-propoxybenzohydrazide |
|
| O9Y | Name: | 2-fluoro-3-methyl-N'-(phenylsulfonyl)-5-(2H-1,2,3-triazol-2-yl)benzohydrazide | Formula: | C16 H14 F N5 O3 S | SMILES: | c3(S(NNC(c1c(c(C)cc(c1)n2nccn2)F)=O)(=O)=O)ccccc3 | InChi: | InChI=1S/C16H14FN5O3S/c1-11-9-12(22-18-7-8-19-22)10-14(15(11)17)16(23)20-21-26(24,25)13-5-3-2-4-6-13/h2-10,21H,1H3,(H,20,23) | Definition date: | 2019-06-19 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 2-fluoro-3-methyl-N'-(phenylsulfonyl)-5-(2H-1,2,3-triazol-2-yl)benzohydrazide |
|
| OJQ | Name: | [2-methyl-3-oxidanyl-5-(phosphonooxymethyl)pyridin-4-yl]methyl-(3-oxidanyl-1,2-oxazol-4-yl)azanium | Formula: | C11 H15 N3 O7 P | SMILES: | Cc1ncc(CO[P](O)(O)=O)c(C[NH2+]c2conc2O)c1O | InChi: | InChI=1S/C11H14N3O7P/c1-6-10(15)8(3-13-9-5-20-14-11(9)16)7(2-12-6)4-21-22(17,18)19/h2,5,13,15H,3-4H2,1H3,(H,14,16)(H2,17,18,19)/p+1 | Definition date: | 2020-03-16 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | [2-methyl-3-oxidanyl-5-(phosphonooxymethyl)pyridin-4-yl]methyl-(3-oxidanyl-1,2-oxazol-4-yl)azanium |
|
| 8XY | Name: | 6-bromo-N-(1H-indol-4-yl)-1-benzothiophene-2-carboxamide | Formula: | C17 H11 Br N2 O S | SMILES: | c4c3cc(C(Nc1cccc2nccc12)=O)sc3cc(Br)c4 | InChi: | InChI=1S/C17H11BrN2OS/c18-11-5-4-10-8-16(22-15(10)9-11)17(21)20-14-3-1-2-13-12(14)6-7-19-13/h1-9,19H,(H,20,21) | Definition date: | 2017-03-18 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 6-bromo-N-(1H-indol-4-yl)-1-benzothiophene-2-carboxamide |
|
| RU4 | Name: | 4-(1,2,3-thiadiazol-4-yl)phenyl ethylcarbamate | Formula: | C11 H11 N3 O2 S | SMILES: | N(C(Oc1ccc(cc1)c2nnsc2)=O)CC | InChi: | InChI=1S/C11H11N3O2S/c1-2-12-11(15)16-9-5-3-8(4-6-9)10-7-17-14-13-10/h3-7H,2H2,1H3,(H,12,15) | Definition date: | 2020-02-25 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 4-(1,2,3-thiadiazol-4-yl)phenyl ethylcarbamate |
|
| RUV | Name: | 4-(acetylamino)-N-(4H-1,2,4-triazol-4-yl)benzamide | Formula: | C11 H11 N5 O2 | SMILES: | N(C(C)=O)c1ccc(cc1)C(=O)Nn2cnnc2 | InChi: | InChI=1S/C11H11N5O2/c1-8(17)14-10-4-2-9(3-5-10)11(18)15-16-6-12-13-7-16/h2-7H,1H3,(H,14,17)(H,15,18) | Definition date: | 2020-02-25 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 4-(acetylamino)-N-(4H-1,2,4-triazol-4-yl)benzamide |
|
| RV4 | Name: | N-{4-[(morpholin-4-yl)methyl]phenyl}acetamide | Formula: | C13 H18 N2 O2 | SMILES: | N(C(C)=O)c1ccc(cc1)CN2CCOCC2 | InChi: | InChI=1S/C13H18N2O2/c1-11(16)14-13-4-2-12(3-5-13)10-15-6-8-17-9-7-15/h2-5H,6-10H2,1H3,(H,14,16) | Definition date: | 2020-02-25 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | N-{4-[(morpholin-4-yl)methyl]phenyl}acetamide |
|
| S3O | Name: | N-[5-(2,3-dimethylphenyl)-1,2,3,4-tetrahydro-1,6-naphthyridin-7-yl]acetamide | Formula: | C18 H21 N3 O | SMILES: | C2CNc1cc(NC(=O)C)nc(c1C2)c3cccc(c3C)C | InChi: | InChI=1S/C18H21N3O/c1-11-6-4-7-14(12(11)2)18-15-8-5-9-19-16(15)10-17(21-18)20-13(3)22/h4,6-7,10,19H,5,8-9H2,1-3H3,(H,20,21,22) | Definition date: | 2019-10-25 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | N-[5-(2,3-dimethylphenyl)-1,2,3,4-tetrahydro-1,6-naphthyridin-7-yl]acetamide |
|
| O6G | Name: | N-(2-cyano-3-methyl-1H-indol-5-yl)butane-1-sulfonamide | Formula: | C14 H17 N3 O2 S | SMILES: | c2(cc1c(C)c(C#N)nc1cc2)NS(CCCC)(=O)=O | InChi: | InChI=1S/C14H17N3O2S/c1-3-4-7-20(18,19)17-11-5-6-13-12(8-11)10(2)14(9-15)16-13/h5-6,8,16-17H,3-4,7H2,1-2H3 | Definition date: | 2019-06-12 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | N-(2-cyano-3-methyl-1H-indol-5-yl)butane-1-sulfonamide |
|
| O6J | Name: | N-(2-cyano-3-methyl-1H-indol-5-yl)pentane-1-sulfonamide | Formula: | C15 H19 N3 O2 S | SMILES: | c1(cc2c(cc1)nc(c2C)C#N)NS(CCCCC)(=O)=O | InChi: | InChI=1S/C15H19N3O2S/c1-3-4-5-8-21(19,20)18-12-6-7-14-13(9-12)11(2)15(10-16)17-14/h6-7,9,17-18H,3-5,8H2,1-2H3 | Definition date: | 2019-06-12 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | N-(2-cyano-3-methyl-1H-indol-5-yl)pentane-1-sulfonamide |
|
| 8JF | Name: | N-[5-(2,3-dimethylphenyl)-1,6-naphthyridin-7-yl]acetamide | Formula: | C18 H17 N3 O | SMILES: | c2cnc1cc(NC(=O)C)nc(c1c2)c3c(C)c(C)ccc3 | InChi: | InChI=1S/C18H17N3O/c1-11-6-4-7-14(12(11)2)18-15-8-5-9-19-16(15)10-17(21-18)20-13(3)22/h4-10H,1-3H3,(H,20,21,22) | Definition date: | 2019-10-25 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | N-[5-(2,3-dimethylphenyl)-1,6-naphthyridin-7-yl]acetamide |
|
| DKU | Name: | 3-[2-(5-methyl-1-phenyl-benzimidazol-2-yl)ethyl]chromen-4-one | Formula: | C25 H20 N2 O2 | SMILES: | Cc1ccc2n(c(CCC3=COc4ccccc4C3=O)nc2c1)c5ccccc5 | InChi: | InChI=1S/C25H20N2O2/c1-17-11-13-22-21(15-17)26-24(27(22)19-7-3-2-4-8-19)14-12-18-16-29-23-10-6-5-9-20(23)25(18)28/h2-11,13,15-16H,12,14H2,1H3 | Definition date: | 2019-08-09 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 3-[2-(5-methyl-1-phenyl-benzimidazol-2-yl)ethyl]chromen-4-one |
|
| DL0 | Name: | 6-chloranyl-3-[2-(5-methyl-1-phenyl-benzimidazol-2-yl)ethyl]chromen-4-one | Formula: | C25 H19 Cl N2 O2 | SMILES: | Cc1ccc2n(c(CCC3=COc4ccc(Cl)cc4C3=O)nc2c1)c5ccccc5 | InChi: | InChI=1S/C25H19ClN2O2/c1-16-7-10-22-21(13-16)27-24(28(22)19-5-3-2-4-6-19)12-8-17-15-30-23-11-9-18(26)14-20(23)25(17)29/h2-7,9-11,13-15H,8,12H2,1H3 | Definition date: | 2019-08-09 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 6-chloranyl-3-[2-(5-methyl-1-phenyl-benzimidazol-2-yl)ethyl]chromen-4-one |
|
| TDJ | Name: | [(1,2,3,4,5-eta)-1-(4-{[carboxy(4-carboxy-5-methylidene-5,6-dihydro-2H-1,3-thiazin-2-yl)methyl]amino}-4-oxobutanoyl)cyclopentadienyl][(1,2,3,4,5-eta)-cyclopentadienyl]ruthenium | Formula: | C22 H13 N2 O6 Ru S | SMILES: | C/%12SC(C(C(=O)O)NC(=O)CCC(C9%10C8C7C%11[Ru]6432789(C1C5C4C3C12)C%10%11)=O)N=C(C%12=C)C(=O)O | InChi: | InChI=1S/C17H17N2O6S.C5H5.Ru/c1-9-8-26-15(19-13(9)16(22)23)14(17(24)25)18-12(21)7-6-11(20)10-4-2-3-5-10 | Definition date: | 2020-03-19 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | [(1,2,3,4,5-eta)-1-(4-{[carboxy(4-carboxy-5-methylidene-5,6-dihydro-2H-1,3-thiazin-2-yl)methyl]amino}-4-oxobutanoyl)cyclopentadienyl][(1,2,3,4,5-eta)-cyclopentadienyl]ruthenium |
|
| C7 | Name: | N-{2-[3-(hydroxyamino)-3-oxopropyl]phenyl}-3-(trifluoromethyl)benzamide | Formula: | C17 H15 F3 N2 O3 | SMILES: | O=C(NO)CCc1c(cccc1)NC(c2cc(ccc2)C(F)(F)F)=O | InChi: | InChI=1S/C17H15F3N2O3/c18-17(19,20)13-6-3-5-12(10-13)16(24)21-14-7-2-1-4-11(14)8-9-15(23)22-25/h1-7,10,25H,8-9H2,(H,21,24)(H,22,23) | Definition date: | 2019-03-27 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | N-{2-[3-(hydroxyamino)-3-oxopropyl]phenyl}-3-(trifluoromethyl)benzamide |
|
| JFX | Name: | 4-fluoro-N-(3-methyl-1H-indazol-5-yl)butane-1-sulfonamide | Formula: | C12 H16 F N3 O2 S | SMILES: | Cc2c1c(ccc(c1)NS(CCCCF)(=O)=O)nn2 | InChi: | InChI=1S/C12H16FN3O2S/c1-9-11-8-10(4-5-12(11)15-14-9)16-19(17,18)7-3-2-6-13/h4-5,8,16H,2-3,6-7H2,1H3,(H,14,15) | Definition date: | 2019-06-12 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 4-fluoro-N-(3-methyl-1H-indazol-5-yl)butane-1-sulfonamide |
|
| JMK | Name: | 2-[4-(1~{H}-indol-3-ylmethyl)piperazin-1-yl]-1,3-benzothiazole | Formula: | C20 H20 N4 S | SMILES: | C1CN(CCN1Cc2c[nH]c3ccccc23)c4sc5ccccc5n4 | InChi: | InChI=1S/C20H20N4S/c1-2-6-17-16(5-1)15(13-21-17)14-23-9-11-24(12-10-23)20-22-18-7-3-4-8-19(18)25-20/h1-8,13,21H,9-12,14H2 | Definition date: | 2019-03-12 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 2-[4-(1~{H}-indol-3-ylmethyl)piperazin-1-yl]-1,3-benzothiazole |
|
| JMN | Name: | (3~{S},4~{S})-4-(3,4-dimethylphenoxy)-1-prop-2-ynyl-piperidin-3-ol | Formula: | C16 H21 N O2 | SMILES: | Cc1ccc(O[CH]2CCN(CC#C)C[CH]2O)cc1C | InChi: | InChI=1S/C16H21NO2/c1-4-8-17-9-7-16(15(18)11-17)19-14-6-5-12(2)13(3)10-14/h1,5-6,10,15-16,18H,7-9,11H2,2-3H3/t15-,16-/m0/s1 | Definition date: | 2019-03-12 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | (3~{S},4~{S})-4-(3,4-dimethylphenoxy)-1-prop-2-ynyl-piperidin-3-ol |
|
| JMT | Name: | 3-[[4-(1,3-benzothiazol-2-yl)piperazin-1-yl]methyl]-1~{H}-indol-5-ol | Formula: | C20 H20 N4 O S | SMILES: | Oc1ccc2[nH]cc(CN3CCN(CC3)c4sc5ccccc5n4)c2c1 | InChi: | InChI=1S/C20H20N4OS/c25-15-5-6-17-16(11-15)14(12-21-17)13-23-7-9-24(10-8-23)20-22-18-3-1-2-4-19(18)26-20/h1-6,11-12,21,25H,7-10,13H2 | Definition date: | 2019-03-12 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 3-[[4-(1,3-benzothiazol-2-yl)piperazin-1-yl]methyl]-1~{H}-indol-5-ol |
|
| JMW | Name: | 3-[[4-(5-chloranyl-1,3-benzothiazol-2-yl)piperazin-1-yl]methyl]-1~{H}-indol-5-ol | Formula: | C20 H19 Cl N4 O S | SMILES: | Oc1ccc2[nH]cc(CN3CCN(CC3)c4sc5ccc(Cl)cc5n4)c2c1 | InChi: | InChI=1S/C20H19ClN4OS/c21-14-1-4-19-18(9-14)23-20(27-19)25-7-5-24(6-8-25)12-13-11-22-17-3-2-15(26)10-16(13)17/h1-4,9-11,22,26H,5-8,12H2 | Definition date: | 2019-03-12 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 3-[[4-(5-chloranyl-1,3-benzothiazol-2-yl)piperazin-1-yl]methyl]-1~{H}-indol-5-ol |
|
| JNE | Name: | 6-methyl-~{N}-(phenylmethyl)pyridin-2-amine | Formula: | C13 H14 N2 | SMILES: | Cc1cccc(NCc2ccccc2)n1 | InChi: | InChI=1S/C13H14N2/c1-11-6-5-9-13(15-11)14-10-12-7-3-2-4-8-12/h2-9H,10H2,1H3,(H,14,15) | Definition date: | 2019-03-13 | Last modified: | 2020-03-27 | Release date: | 2020-04-01 | Identifier: | 6-methyl-~{N}-(phenylmethyl)pyridin-2-amine |
|